Help
Subscribe


GastroHep.com - the global online resource for all aspects of gastroenterology, hepatology and endoscopy

 05 May 2016

Advanced search
GastroHep.com - the global online resource for all aspects of gastroenterology, hepatology and endoscopy Profile of Roy Pounder

Home

News  
Journals
Review Articles
Slide Atlas
Video Clips
Online Books
Advanced Digestive Endoscopy
Classical Cases
Conference Diary
PubMed
International GH Links
USA GH Links
National GH Links
National GI Societies
Other Useful Links




Emails on Gastroenterology and Hepatology
the National AIDS Treatment Advocacy Project
Visit the gastroenterology section of the EUMS

News

Vitamin B12 supplementation improves rates of sustained viral response in HCV

Vitamin B12 supplementation improves rates of sustained viral response in patients chronically infected with hepatitis C virus, finds May's issue of Gut.

News image

In vitro, vitamin B12 acts as a natural inhibitor of hepatitis C virus (HCV) replication.

Dr Alba Rocco from Italy assessed the effect of vitamin B12 on virological response in patients with chronic hepatitis C virus hepatitis naÔve to antiviral therapy.

The research team randomly assigned 94 patients with chronic hepatitis C virus hepatitis to receive pegylated interferon α plus ribavirin or SOC plus vitamin B12.

Viral responseónamely, undetectable serum HCV-RNA, was evaluated 4 weeks after starting treatment, 12 weeks after starting treatment and 24 or 48 weeks after starting treatment and 24 weeks after completing treatment.

Genotyping for the interleukin (IL)-28B polymorphism was performed a posteriori in a subset of hepatitis C virus genotype 1 carriers.

The team of researchers noted that overall, rapid viral response did not differ between the 2 groups.

The rates of complete early viral response, end-of-treatment viral response and hepatitis C virus were significantly higher in SOC+B12 patients than in SOC patients.

Only easy-to-treat HCV genotypes were independently associated with sustained virological response
Gut 

In SOC+B12 patients, the sustained virological rate was also significantly higher in carriers of a difficult-to-treat genotype, and in patients with a high baseline viral load.

The doctors noted that distribution of genotype IL-28B did not differ between the 2 groups.

At multivariate analysis, only easy-to-treat HCV genotypes and vitamin B12 supplementation were independently associated with sustained virological response.

Dr Rocco's team commented, "Vitamin B12 supplementation significantly improves sustained virological response rates in HCV-infected patients naÔve to antiviral therapy."

Gut 2013; 62: 766-773
11 April 2013

Go to top of page Email this page Email this page to a colleague

 05 May 2016 
Genetics in early-early-onset IBD
 05 May 2016 
Reductions in quality of screening colonoscopies
 05 May 2016 
Chemoradiotherapy vs chemotherapy for pancreatic cancer
 04 May 2016 
Bismuth and H. pylori eradication
 04 May 2016 
Chromoendoscopy vs colonoscopy for dysplasia in colitis
 04 May 2016 
Anti-TNF therapy for IBD
 03 May 2016 
Surgery vs medical therapy for GERD
 03 May 2016 
Vedolizumab for IBD
 03 May 2016 
PPIs and gut microbiota
 02 May 2016 
Resection of colorectal polyps
 02 May 2016 
Genetic variant that increase NAFLD risk
 02 May 2016 
Mycophenolate mofetil as first-line treatment of autoimmune hepatitis
 29 April 2016 
Crohn's disease associated genes
 29 April 2016 
Simvastatins and survival in cirrhosis
 29 April 2016 
HCV infection in Baby Boomers with Medicare
 28 April 2016 
Racial disparities in survival from colon cancer
 28 April 2016 
Diarrheal diseases in children
 28 April 2016 
Birth outcomes in women with IBD receiving assisted reproduction
 27 April 2016 
Dust mite and human GI tract
 27 April 2016 
Ultra-short celiac disease
 27 April 2016 
Celiac disease in adults
 26 April 2016 
Polyp detection during colonoscopy
 26 April 2016 
Guidelines for nutrition therapy in hospitalized patients
 26 April 2016 
IBS and microscopic colitis
 25 April 2016 
Estrogen deficiency and fibrosis risk in women with NAFLD
 25 April 2016 
Abrupt interruption of beta-blockers in cirrhosis 
 25 April 2016 
Acceptance of Liver transplant center organ offers
 22 April 2016 
Novel method to regenerate the esophagus
 22 April 2016 
Relapse after antiviral treatment in Hep B
 22 April 2016 
Microscopic colitis with NSAIDs and PPIs
 11 April 2016 
Infliximab vs adalimumab in ulcerative colitis
 11 April 2016 
H. pylori in treatment-naÔve children
 11 April 2016 
Admissions times and outcomes for ERCP cholangitis
 08 April 2016 
Endoscopic treatment of Crohn's strictures
 08 April 2016 
Nutrition therapy in the hospitalized patient
 08 April 2016 
H.pylori effects on pediatric gastric mucosa
 07 April 2016 
CVD changes after TIPSS
 07 April 2016 
Transanal mesorectal resection for rectal cancer
 07 April 2016 
HBV during immunosuppressive therapies
 06 April 2016 
Adherence to colorectal cancer screening strategies
 06 April 2016 
Duodenal bulb biopsies in childhood celiac disease diagnosis
 06 April 2016 
Lymph node metastasis in early gastric cancer
 05 April 2016 
Colorectal cancer risk with serrated polyps
 05 April 2016 
IBS in the US military
 05 April 2016 
Changes in blood flow in cirrhosis
 04 April 2016 
Noninvasive diagnosis of celiac disease
 04 April 2016 
Metallic vs plastic stents for benign biliary strictures
 04 April 2016 
Adherence to quality indicators improves clinical outcomes in ascites
 01 April 2016 
Intensive enteral nutrition and severe alcoholic hepatitis
 01 April 2016 
Prognosis after colorectal cancer resection with peritoneal metastasis
 01 April 2016 
Colorectal cancer risk with non-malignant colonoscopy findings
 31 March 2016 
Management of Barrettís esophagus
 31 March 2016 
Anesthesia services during colonoscopy
 31 March 2016 
Alcohol and glucose tolerance in NAFLD
 30 March 2016 
Electronic learning system for colon capsule endoscopy
 30 March 2016 
Gastric cancer screening
 30 March 2016 
Depression and symptoms in IBS
 29 March 2016 
Infant feeding practices and celiac disease
 29 March 2016 
Statins and survival in esophageal cancer
 25 March 2016 
Medical therapy and neoplasia regression in familial adenomatous polyposis

Blackwell Publishing


GastroHep.com is a Blackwell Publishing registered trademark
© 2016 Wiley-Blackwell and GastroHep.com and contributors
Privacy Statement
Disclaimer
About Us